Gareth Waldron
Reducing Safety-Related Drug Attrition- An Interview with Gareth Waldron
December 16 by Gerald ClarkeSafety-related drug attrition is obviously a huge problem in drug trials. How can companies work to reduce this? We spoke with Gareth Waldron Non-Clinical Safety Lead at Pfizer Neusentis about in vi...